跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
醫學系外科學科
醫學院
醫學系
概覽
指紋
網路
人員
(5)
研究成果
(754)
指紋
查看啟用 醫學系外科學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Stereotactic Radiosurgery
100%
Colorectal Cancer
88%
Tumor
48%
Gastric Cancer
43%
Gamma Knife Radiosurgery
43%
Overall Survival
39%
Colorectal Cancer Patients
37%
Taiwan
33%
Brain Metastases
32%
Metastatic Colorectal Cancer (mCRC)
32%
Radiosurgery
30%
Arteriovenous Malformation
28%
Prognostic Factors
24%
Gastric Cancer Patients
24%
International multicenter Study
21%
Multivariate Analysis
21%
Brain Arteriovenous Malformation (bAVM)
20%
Microsatellite Instability-high (MSI-H)
19%
Taipei
18%
Curative Surgery
18%
Lymph Node Metastasis
18%
Carcinoembryonic Antigen
17%
5-year Survival
17%
General Hospital
17%
Chemotherapy
17%
Overexpression
16%
Disease-free Survival
16%
Cerebral Arteriovenous Malformation
16%
Colon Cancer
15%
Hazard Ratio
15%
Resection
15%
Obliteration
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Magnetic Resonance Imaging
14%
Confidence Interval
13%
Patients with Colorectal Cancer
13%
Independent Prognostic Factor
12%
Carcinoembryonic Antigen Levels
12%
5-fluorouracil (5-FU)
12%
Curative Resection
12%
Risk Factors
12%
Poor Prognosis
12%
Dural Arteriovenous Fistula (dAVF)
11%
Clinical Significance
11%
Carcinoma
11%
Surgical Outcomes
11%
Vestibular Schwannoma
10%
Tumor Volume
10%
Prognostic Value
10%
National Cohort Study
10%
Clinical Papers
10%
Distant Metastasis
10%
Tumor Size
10%
Colorectal Cancer Cells
10%
Genetic Modification
10%
Clinical Outcomes
9%
Gastric Carcinoma
9%
Completely Resected
9%
Lung Adenocarcinoma
9%
Gastric Adenocarcinoma
9%
Stomach
9%
Metastasis
9%
Tumor Recurrence
9%
Liver Metastasis
9%
High Risk
9%
Meningioma
8%
Local Tumor Control
8%
Leucovorin
8%
Surgical Resection
8%
Prognostic Significance
8%
Lymphovascular Invasion
8%
Colon Cancer Cells
8%
Patient Survival
8%
Multi-institutional Study
8%
Tumor Control
7%
Univariate Analysis
7%
Progression-free Survival
7%
Tumor Cells
7%
After Surgery
7%
Oxaliplatin
7%
Survival Rate
7%
Digital Subtraction Angiography
7%
Right-sided Colon Cancer
7%
Odds Ratio
7%
Treatment Outcome
7%
Overall Survival Rate
7%
Prognostic Indicator
6%
Young Patients
6%
Polymorphism
6%
Transanal Total Mesorectal Excision (taTME)
6%
Adverse Radiation Effect
6%
Embolization
6%
Gastrectomy
6%
Colorectal Carcinoma
6%
FOLFOX
6%
Mortality Rate
6%
Intracranial Dural Arteriovenous Fistula
6%
Meta-analysis
6%
Repeat Stereotactic Radiosurgery
6%
Taiwanese
6%
Medicine and Dentistry
Neoplasm
90%
Stereotactic Radiosurgery
86%
Colorectal Carcinoma
78%
Abdominal Cancer
56%
Surgery
45%
Overall Survival
43%
Recurrent Disease
34%
Prognostic Factor
30%
Brain Metastasis
29%
Arteriovenous Malformation
28%
Diseases
27%
Bleeding
26%
Metastatic Carcinoma
25%
Radiosurgery
25%
Colon Carcinoma
22%
Rectum Cancer
22%
Gamma Knife Radiosurgery
21%
Survival Rate
20%
Cohort Analysis
20%
Gastrectomy
20%
Lymph Node Metastasis
20%
Cerebral Arteriovenous Malformation
19%
Disease Free Survival
17%
Carcinoembryonic Antigen
16%
Malignant Neoplasm
16%
Multivariate Analysis
15%
Lung Cancer
14%
Lymph Node
13%
Dural Arteriovenous Fistula
13%
Non Small Cell Lung Cancer
12%
Breast Cancer
12%
Chemoradiotherapy
11%
Hazard Ratio
11%
Magnetic Resonance Imaging
10%
Retrospective Study
10%
Lung Adenocarcinoma
10%
Meningioma
10%
Carcinoma
9%
Liver Metastasis
9%
Gene Mutation
9%
Cancer Cell
9%
Cancer
8%
Proportional Hazards Model
8%
Laparoscopic Surgery
8%
Free Tissue Graft
8%
Microsatellite Instability
7%
Stomach Carcinoma
7%
Embolization
7%
Distant Metastasis
7%
Radiation Therapy
7%
Metastasectomy
7%
Stomach Adenocarcinoma
7%
Lymphovascular Invasion
7%
Carcinogenesis
7%
Adenocarcinoma
7%
Vestibular Schwannoma
7%
Progression Free Survival
6%
Metastatic Colorectal Cancer
6%
Total Mesorectal Excision
6%
Primary Tumor
6%
Tumor Recurrence
6%
Retroperitoneal Lymph Node Dissection
6%
Tumor Progression
6%
Mortality Rate
6%
Univariate Analysis
6%
Pediatrics
6%
Apoplexy
6%
In Vitro
6%
Cavernous Sinus
6%
Odds Ratio
5%
Meta-Analysis
5%
Tumor Cell
5%
Retrospective Cohort Study
5%
Randomized Controlled Trial
5%
Epidermal Growth Factor Receptor
5%
Pneumonectomy
5%
Intracranial Tumor
5%
Colorectal Surgery
5%
Quality of Life
5%
Radiation Response
5%
Biological Marker
5%
Colon
5%
Squamous Cell Carcinoma
5%
Radiation Necrosis
5%
Fasciocutaneous Flap
5%